News

Genoskin reinforces R&D capabilities Genoskin Research & Development offers new services to portfolio available to partners with the addition of new equipment. Genoskin's R&D recently added a Meso Scale QuickPlex SQ120 for high-performance electroluminescence immunoassays. This new instrument will enable our teams to detect the presence of biomarkers down to femtoscale concentrations. Genoskin also added a best-in-class solar simulator (Solar Light) capable ofRead more

Genoskin wishes you the best for 2020, the Year of the Rat! Thank you so much for your trust and support, 2019 was another amazing year! We can't wait to continue our partnership this year. And since 2020 is also the Year of the Rat, let's work together to keep the rats out of the labs and generate better dataRead more

Genoskin's CEO, Pascal Descargues to speak at the first FACCNE 'Café des Sciences' of 2020! Meet our CEO Pascal at the WeWork building on January 23  and discover everything about our real live human skin assays.  2020 welcomes a new year of Café des Sciences, and Pascal is the first speaker invited! Pascal will give a presentation on how toRead more

Incospharm publishes results using NativeSkin® Korean company Incospharm publishes data generated using our hi-tech human skin assay, NativeSkin®, in the International Journal of Molecular Sciences. Incospharm developed an innovative complex of peptides meant to stimulate the skin basement membrane proteins expression for anti-aging effects. The ex vivo evaluation using NativeSkin® confirmed that the topical application of this peptide complex significantlyRead more

Team-up with Genoskin to share data at the 59th Annual Meeting of the Society Of Toxicology and ToxExpo (SOT2020) The Annual Meeting of the Society Of Toxicology (SOT2020) is getting closer! From March 15 to March 20, Genoskin will be exhibiting in Anaheim, CA (Booth #1200). Take the opportunity to meet our team and learn more about our products and services.Read more

Genoskin invited at FDA to present ex vivo human skin models validation data On November 14th, 2019, Pascal Descargues (Chief Executive Officer) and Eric Merle (Chief Commercial Officer) were invited by the FDA Immunotoxicology Interest group of the US Food and Drug Administration in Silver Spring, MD to present at the FDA Toxicology Seminar Series on HypoSkin® and NativeSkin® validation data. GenoskinRead more